2025 APRN/PA Pediatric Pharmacology Update

Objectives (Educational Content) :

In-Person and On-Demand Presentations

 

Unplugging the Problem: Pediatric Constipation Through a Pharmacologic Lens
Matthew Wyneski, MD - Gastroenterology

• Identify the underlying causes of constipation in pediatric patients.
• Evaluate and implement evidence-based pharmacological treatments for pediatric constipation.
• Assess and manage potential side effects and long-term complications of constipation medications.

Download presentation (PDF) | Video presentation
 

 

Seize Control: Antiseizure Medications Demystified
Francesca Shick, MSPAS, PA-C - Neurology

• Describe the pharmacological treatment options for pediatric seizures.
• Assess and manage potential side effects and drug interactions in pediatric seizure medications.
• Develop individualized seizure management plans and monitor treatment efficacy.

Download presentation (PDF) | Video presentation
 

More Than Milk: The Intersection of Breastfeeding and Pediatric Pharmacology
Carly Dulabon, MD, IBCLC, NABBLM-C – Breastfeeding Medicine

• Describe the pharmacokinetics of medications in breastfeeding mothers.
• Identify safe pharmacological interventions for breastfeeding mothers.
• Develop evidence-based strategies for managing maternal health conditions while supporting breastfeeding.

Download presentation (PDF) | Video presentation
 

Pharmacologic Management of Pediatric Ocular Conditions: From Drops to Systemics
Valerie Russell, PA-C - Ophthalmology

• Review indications, contraindications and side effects of common ophthalmic medications such as antibiotics, anti-inflammatory agents, mydriatics and glaucoma treatments.
• Explain best practices for diagnosing and managing common pediatric ophthalmic conditions, such as conjunctivitis, uveitis and amblyopia.
• Discuss the pharmacokinetics and pharmacodynamics of pediatric ophthalmic medications.

Download presentation (PDF) | Video presentation
 

From Labs to Lipid-Lowering: Pharmacologic Treatment of Hyperlipidemia in Children and Adolescents Robert VandeKappelle Jr, MD

• Describe the pathophysiology and risk factors of pediatric hyperlipidemia.
• Evaluate pharmacologic and non-pharmacologic treatment strategies for pediatric hyperlipidemia.
• Review current guidelines from the American Academy of Pediatrics and the National Heart, Lung and Blood Institute regarding lipid screening and treatment thresholds.

Download presentation (PDF) | Video presentation
 

 

Controlled but Necessary: Clinical use of Schedule II Medications in Pediatric Care
Alyssa Kuhn, PharmD, BCPPS - Neonatal Intensive Care; and JoEllen Weilnau, PharmD - Pediatric Hematology/Oncology/Bone Marrow Transplant

• Review the mechanisms of action, therapeutic uses and risks associated with commonly prescribed Schedule II medications and opioids. 
• Discuss DEA regulations, prescribing restrictions, and state-specific laws affecting the use of Schedule II medications in pediatric practice.
• Explore alternative therapies and multimodal approaches to pain management to minimize reliance on Schedule II medications.

 

Download presentation (PDF) | Video presentation

Target Audience:

Nurse practitioners, nurse anesthetists, clinical nurse specialists, physician assistants, physicians, registered nurses and other professionals who work with children will benefit from attending this conference.

Estimated Time to Complete the Educational Activity:

6 hour(s)

Expiration Date for CE/CME Credit:

12-01-2025

Method of Participation in the Learning Process:

The learner will view the on-demand presentations and complete an activity evaluation.

Evaluation Methods:

All learners must complete an attestation and evaluation to claim credit.

Disclosure:

None of the planners or presenters for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Accreditation Statement:

This program has been approved for 6 AAPA Category 1 CME credits and 6 contact hours of ANCC CE Pharmacology credit, of which 1 hour is Schedule II pharmacology specific.

Note: Conference content must be viewed between Oct 1^st, 2025, and Dec 1^st, 2025.   
CE/CME evaluation will be available until January 1^st, 2026, via CME Tracker.  

At the end of this period, no CE/CME will be awarded.    

Speakers:

Unplugging the Problem: Pediatric Constipation through a Pharmacological Lens
Matthew Wyneski, MD

Pharmacologic Management of Pediatric Ocular Conditions: From Drops to Systemics
Valerie Russell, PA-C

From Labs to Lipid-Lowering: Pharmacologic Treatment of Hyperlipidemia in Children and Adolescents
Robert VandeKappelle Jr, MD

Controlled but Necessary: Clinical use of Schedule II Medications in Pediatric Care
Alyssa Kuhn, PharmD, BCPPS & JoEllen Weilnau, PharmD

Seize Control: Antiseizure Medications Demystified
Francesca Shick, MSPAS, PA-C

More Than Milk: The Intersection of Breastfeeding and Pediatric Pharmacology
Carly Dulabon, MD, IBCLC, NABBLM-C